cbdMD Inc

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded by Caryn Dunayer on March 17, 2015 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”) , one of the world's leading, and most highly trusted and recognized CBD health and wellness companies, announced today that it is entering the global beauty and skincare market with the brand's launch of “cbdMD Botanicals”. The new beauty and skincare line features 15 luxury products, including: Facial Oil and Serum, Toner, Moisturizers, Clearskin, Facial Masks, Exfoliants, and Body Care. “cbdMD Botanic

cbdMD Enters Global Beauty and Skincare Market With Launch of “cbdMD Botanicals”

SNDL Inc.

Tilray Brands

Village Farms International

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks in the final week of 2020, and look ahead to how the cannabis industry will develop in the new year.

4 Smoking Hot Cannabis Stocks Rolling Into 2021

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that the company is expanding its direct-to-consumer operations into the United Kingdom (U.K.), officially launching its new website exclusively for customers in the U.K. Expanding upon the CBD brand's comprehensive, wholesale-focused partnership with European-based distribution company, Ultra Sport EU,

cbdMD Grows Direct-to-Consumer Footprint with U.K. Expansion

Canopy Growth

GW Pharmaceuticals

HEXO Corp

OrganiGram Holdings Inc.

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this past week and look ahead to how the cannabis industry will develop in the new year.

Six Cannabis Stocks Getting Busy Ahead of a 'Green Christmas'

Seeking Alpha Transcripts | Services cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q4 2020 Results - Earnings Call Transcript Dec. 22, 2020 7:23 PM ET | | About: cbdMD, Inc. (YCBD), YCBD.PA by: SA Transcripts Subscribers Only Earning Call Audio cbdMD, Inc. (NYSEMKT:YCBD) Q4 2020 Earnings Conference Call December 22, 2020 4:15 PM ET Company Participants Ronan Kennedy - CFO Marty Sumichrast - Chairman and Co-CEO

cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q4 2020 Results - Earnings Call Transcript

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, today announced its financial results for the fourth quarter and fiscal year ended September 30, 2020. Commenting on today's results, Chairman and co-CEO Martin A. Sumichrast said, “We believe cbdMD is now one of the most successful CBD companies in world, with two of the most recognized and valuable CBD brands, cbdMD and Paw C

cbdMD Reports Fiscal September 30, 2020 Results

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Tuesday, December 22, 2020, to discuss the company's September 30, 2020 fourth quarter and fiscal year end financial results and business progress. CONFERENCE CALL DETAILS Tuesday, December 22, 2020, 4:15 p.m. Eastern Time   Domestic: 1-888-506-0

cbdMD, Inc. To Host Conference Call To Discuss September 30, 2020, Fourth Quarter and Fiscal Year End Results

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) announced that regional grocer Save Mart has agreed to expand their cbdMD product offerings to additional locations due to strong retail sales performance and sell through of cbdMD and Paw CBD brands. The Save Mart Companies, a regional grocer which owns and operates stores under the banners of Save Mart, Lucky, Lucky California and FoodMaxx throughout California and Northern Nevada, has expanded their cbdMD and Paw

Strong Retail Sales Performance and Sell Through Result In Regional Grocer Save Mart To Expand cbdMD and Paw CBD Brand Offerings To Additional 100 Locations

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), today announced the closing of its previously announced underwritten public offering for total gross proceeds of $17,250,000, before deducting underwriting discounts, commissions and other offering expenses payable by the company. cbdMD, Inc. sold an aggregate of 2,300,000 shares of its 8.0% Series A Cumulative Convertible Preferred Stock at a purchase price of $7.50 per share in this offering which included the full e

cbdMD, Inc. Announces Closing of $17,250,000 Underwritten Public Offering of Its 8.0% Series A Cumulative Convertible Preferred Stock

Anchiano Therapeutics Ltd - ADR

Titan Medical Inc

Zhongchao

As of Dec. 10, the GuruFocus All-in-One Screener, a Premium feature, found that the following health care companies have low price-earnings ratios and are owned by gurus. While some of them are great value investments, others may need to be researched more carefully, according to the discounted cash flow calculator.

6 Health Care Stocks Trading With Low Price-Earnings Ratios

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) today announced the pricing of its underwritten public offering of 2,000,000 shares of its 8.0% Series A Cumulative Convertible Preferred Stock at a price to the public of $7.50 per share. cbdMD expects to receive gross proceeds of $15,000,000 from the offering. The closing of the offering is expected to occur on or about December 11, 2020, subject to the satisfaction of customary closing conditions. The shares will be

cbdMD, Inc. Announces Pricing of $15 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, today announced that Martin Sumichrast, Chairman & Co-CEO, is scheduled to speak on the CBD panel at the Cowen 2020 Boston Cannabis Conference on Tuesday, December 1, 2020 at 1:30 p.m. EST. For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/

cbdMD Announces Speaking Engagement at the Cowen 2020 Boston Cannabis Conference

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a company. This time it may be different. The coronavirus pandemic destroyed the high correlations among major industries and asset classes. We are now in a stock pickers market where fundamentals of a stock have more effect on the price than the overall direction of the market. As a result we observe sudden and large changes in hedge fund positions depending on the news flow. Let's take a look at the hedge fund sentiment towards cbdMD, Inc. (NYSE:YCBD) to find out whether there were any major changes in hedge funds' views.

Is cbdMD, Inc. (YCBD) A Good Stock To Buy Now?

Aurora Cannabis

Arena Pharmaceuticals

FSD Pharma

Akerna Corp

Zynerba Pharmaceuticals

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and we will look ahead at the pot stocks to watch in the upcoming week.

11 Cannabis Stocks Making Moves While Riding the 'Green Wave'

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it will be participating in the Jefferies Virtual West Coast Consumer Conference, November 16-18, 2020. cbdMD Co-CEO & President, Scott Coffman, will be the guest speaker for the company's Fireside Chat session, with Jefferies analyst, Owen Bennett. The presentation and Q&A session will take plac

cbdMD Announces Participation in Jefferies Virtual West Coast Consumer Conference

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has retained nationally recognized biotechnology company IONTOX (https://www.iontox.com), to validate the Company's patent pending proprietary cannabinoid formulations. On July 9, 2020, cbdMD announced it had filed provisional patents on its novel formulations and delivery systems. This is the next st

cbdMD Engages Leading Biotech Firm IONTOX to Validate Its Patent Pending Superior Broad Spectrum Blend

Cia Brasileira de Distribuicao

Cisco Systems

Chevron

Honeywell

Intel

JPMorgan Chase & Co

Leap Therapeutics

UnitedHealth Group

Verizon

Walmart

Two new breakout stocks for Week 46 with better than 10% short-term upside potential. This past week three out of four stocks gained more than 10% closing with gains to Friday with AVNS +8.54%, IMVT +14.96%, YY +10.85% with top average portfolio gains of 11.14%.

Week 46 MDA Breakout Forecast - November: Short-Term Picks To Give You An Edge

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD.PR.A), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, confirmed today that it is on track to submit its Novel Foods Dossier with the United Kingdom's Food Safety Agency (FSA) by the required regulatory filing deadline of March 31, 2021. “By allowing CBD product manufacturers to obtain a Novel Food Authorization from the FSA, the UK is now leading the world in CBD regulation. cb

cbdMD Seeks To Obtain Regulatory Approval From United Kingdom's Regulatory Food Safety Agency (FSA)

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A), one of the nation's leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that USA Today's GolfWeek published a story on October 28, 2020 about two time Masters Champion, and Team cbdMD Athlete, Bubba Watson, in which Bubba discussed his personal and professional anxieties and cbdMD's role relative to his ongoing health and wellness regimen. The story details that “about 18 months

USA Today's Golfweek Reports On Professional Golfer Bubba Watson's Battle With Anxieties; cbdMD Plays Strong Role in his Ongoing Health and Wellness Journey

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading and most highly trusted and recognized cannabidiol (CBD) brands, announced today that its CBD pet products brand, Paw CBD, has experienced another record quarter of net sales. Paw CBD's September 30, 2020, estimated preliminary quarterly net sales are expected to range between $1.6 million and $1.65 million, or a sequential quarterly growth of between 30% and 34% from the $1.23 mil

cbdMD, Inc. Reports Preliminary Fourth Quarter Fiscal 2020 Net Sales For Its Paw CBD Brand; Sequential Quarterly Net Sales Expected to Increase Between 30% and 34%

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) announced today that Life Time, the nation's premier healthy lifestyle brand, will be expanding their cbdMD product sales into all its Life Time Cafes nationwide as of November 1, 2020, due to the brands' strong retail sales performance and sell through. As a wellness pioneer, Life Time is reshaping the way consumers approach their health by integrating where consumers play, work and live – all with the primary objec

Life Time To Expand cbdMD Product Sales In All Cafes Due To Strong Retail Sales Performance and Sell Through

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, highly trusted, and most recognized cannabidiol (CBD) brands, today reported the following preliminary financial results for the fourth quarter of fiscal 2020 and the year ended September 30, 2020. Net sales revenue for fiscal 2020 is expected to range between $41.7 and $41.8 compared to $23.7 million in fiscal 2019. Net sales revenue for the fourth quarter of fiscal 2020 is expec

cbdMD Reports Preliminary Fourth Quarter and Fiscal 2020 Results

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, most highly trusted, and most recognized cannabidiol (CBD) brands, announced today that PRO Group, Inc. (www.pro-group.com), a multidivisional international merchandising and marketing organization, with over 79 distributors operating over 140 distribution centers serving all 50 states and combined sales volume exceeding $6 billion through its member distributors and an alliance w

Distribution Company PRO Group, Inc. Selects cbdMD and Paw CBD As Exclusive CBD Brands

OKLAHOMA CITY--(BUSINESS WIRE)-- #CBDIndustries--Federman & Sherwood Initiates an Investigation of the Data Breach at cbdMD, Inc.

Federman & Sherwood Initiates an Investigation of the Data Breach at cbdMD, Inc.

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBD PR A) (the “Company”), one of the leading, most highly trusted, and most recognized cannabidiol (CBD) brands, announced today that in conjunction with the Natural Products Association (NPA), with the goal to better clarify the landscape for investors, is launching an invitation only virtual investor conference entitled “Regulatory Roadmap For The CBD Industry”, which will focus on discussing the current regulatory climate

cbdMD and The Natural Products Association Launch “Regulatory Roadmap For The CBD Industry”

News for cbdMD Inc Stock (YCBD)